According to Yield10 Bioscience's latest financial reports and stock price the company's current Operating Margin is -1,354.51%. At the end of 2022 the company had an Operating Margin of -2,980.00%.
Year | Operating Margin | Change |
---|---|---|
2022 | -2,980.00% | 66.41% |
2021 | -1,790.72% | 40.96% |
2020 | -1,270.34% | -22.49% |
2019 | -1,638.96% | -0.79% |
2018 | -1,651.98% | 65.97% |
2017 | -995.34% | 12.15% |
2016 | -887.49% | -3.69% |
2015 | -921.48% | -3.61% |
2014 | -956.00% | 26.53% |
2013 | -755.53% | -8003.1% |
2012 | 9.56% | -100.35% |
2011 | -2,721.75% | -68.58% |
2010 | -8,661.38% | 218.69% |
2009 | -2,717.82% | 8.67% |
2008 | -2,501.09% | 24.48% |
2007 | -2,009.27% | 426.28% |
2006 | -381.79% | 51.14% |
2005 | -252.61% | 85.82% |
2004 | -135.94% | -235.94% |
2003 | 100.00% | -139.28% |
2002 | -254.60% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
26.89% | -101.99% | ๐บ๐ธ USA | |
-234,760.00% | 17,231.73% | Bahamas |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.